AI Analysis AI Analysis of INVA
AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment
Trading Strategy
PDF

Stronger technical forecast for Innoviva, Inc stock price after Monday trading
(Updated on Nov 17, 2025)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Buy or Hold candidate since Oct 31, 2025 Gain 20.71%

The Innoviva, Inc stock price fell by -1.26% on the last day (Monday, 17th Nov 2025) from $22.25 to $21.97. During the last trading day the stock fluctuated 2.39% from a day low at $21.97 to a day high of $22.50. The price has risen in 8 of the last 10 days and is up by 21.31% over the past 2 weeks. Volume has increased on the last day by 136 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 886 thousand shares were bought and sold for approximately $19.46 million.

The stock lies the upper part of a very wide and falling trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $22.24 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the stock is expected to fall -3.88% during the next 3 months and, with a 90% probability hold a price between $15.70 and $21.38 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

INVA Signals & Forecast

The Innoviva, Inc stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $21.76 and $18.55. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Wednesday, November 12, 2025, and so far it has fallen -1.39%. Further fall is indicated until a new bottom pivot has been found. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for Innoviva, Inc stock

On the downside, the stock finds support just below today's level from accumulated volume at $20.58 and $19.19. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Innoviva, Inc finds support just below today's level at $20.58. If this is broken, then the next support from accumulated volume will be at $19.19 and $18.35.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.525 between high and low, or 2.39%. For the last week, the stock has had daily average volatility of 3.59%.

The Innoviva, Inc stock is overbought on RSI14 and lies in the upper part of the trend. Normally this may pose a good selling opportunity for the short-term trader, but some stock may go long and hard while being overbought. Regardless, the high RSI together with the trend position increases the risk and higher daily movements (volatility) should be expected. A correction down in the nearby future seems very likely and it is of great importance that the stock manages to break the trend before that occurs.

Our recommended stop-loss: $21.38 (-2.69%) (This stock has high daily movements and this gives high risk. The RSI14 is 89 and this increases the risk substantially. There is a sell signal from a pivot top found 3 days ago.)

Trading Expectations (INVA) For The Upcoming Trading Day Of Tuesday 18th

For the upcoming trading day on Tuesday, 18th we expect Innoviva, Inc to open at $22.15, and during the day (based on 14 day Average True Range), to move between $21.62 and $22.32, which gives a possible trading interval of +/-$0.694 (+/-3.21%) up or down from last closing price. If Innoviva, Inc takes out the full calculated possible swing range there will be an estimated 3.21% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $22.20 (1.05%) than the support at $20.58 (6.33%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Innoviva, Inc stock A Buy?

Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Buy candidate.

Current score: 1.318 Buy Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on November 18, 2025 - $22.15 ( 0.797%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk

INVA Performance

Trading levels for INVA

Full Access. No Commitment. 14 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 5 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 22.67 3.19%
R2 22.47 2.27%
R1 22.35 1.71%
Price 21.97
S1 21.94 -0.116%
S2 21.82 -0.680%
S3 21.62 -1.59%

Accumulated Volume Support & Resistance Levels

Level Price
R3 22.28 1.41%
R2 22.25 1.27%
R1 22.20 1.05%
Price 21.97
S1 20.58 -6.33%
S2 19.19 -12.65%
S3 18.35 -16.48%

INVA Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Jul 30, 2015 Sep 08, 2015 Sep 30, 2015 $0.250 3.48%
2 May 06, 2015 Jun 10, 2015 Jun 30, 2015 $0.250 1.41%
3 Feb 23, 2015 Mar 10, 2015 Mar 31, 2015 $0.250 1.64%
4 Oct 16, 2014 Nov 21, 2014 Dec 23, 2014 $0.250 1.82%
5 Aug 06, 2014 Aug 26, 2014 Sep 18, 2014 $0.250 1.43%

FAQ

What is the symbol for Innoviva, Inc Stock and on which exchange is it traded?
The symbol for Innoviva, Inc is INVA and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Innoviva, Inc Stock?
Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Buy candidate.

How to buy Innoviva, Inc Stock?
Innoviva, Inc Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Innoviva, Inc Stock.

What's the current price of Innoviva, Inc Stock?
As of the end of day on the Nov 17, 2025, the price of an Innoviva, Inc (INVA) share was $21.97.

What is the 52-week high and low for Innoviva, Inc Stock?
The 52-week high for Innoviva, Inc Stock is $22.76 and the 52-week low is $16.52.

What is the market capitalization of Innoviva, Inc Stock?
As of the Nov 17, 2025, the market capitalization of Innoviva, Inc is 1.413B.

When is the next earnings date for Innoviva, Inc?
The upcoming earnings date for Innoviva, Inc is Feb 25, 2026.
Click to get the best stock tips daily for free!
ABOUT INNOVIVA, INC
Innoviva
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a long-acting muscarinic antagonist (LAMA), umeclidinium bromide (UMEC), with a LABA, and VI; and TRELEGY...
GOLDEN STAR
Ticker Change Signal Date
UNIT
$6.00
4.83% Nov 04
TBPH
$14.14
27.58% Oct 23
A
AMIX
$1.12
2.68% Oct 23
COCO
$40.85
11.21% Oct 23
LAUR
$29.55
1.20% Oct 22

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE